Episode
MASLD with Sven Francque - Part 2
- Podcast
- UEG Podcast
- Published
- Jun 2, 2026
- Duration seconds
- 1685
- Processing state
not_requested- Canonical source
- https://ueg-talks-podcast.podigee.io/77-new-episode
Actions
POST https://stenobird.com/v1/public/podcasts/ueg-podcast-6404464/episodes/masld-with-sven-francque-part-2/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/ueg-podcast-6404464/masld-with-sven-francque-part-2.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
The 2024 MASLD treatment guidelines are already changing. Pradeep Mundre and Professor Sven Francque (Antwerp), guideline co-author, cover weight-loss targets (7% and 10%), resmetirom in F2-F3 fibrosis, semaglutide's positive phase 3 in MASH, plus pioglitazone, bariatric surgery, and liver transplantation in this population.